The Board has fixed Friday, July 03, 2026, as the "Record Date" to ascertain the eligibility of the shareholders for the payment of final cum special dividend.
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Akums Drugs and Pharmaceuticals has fixed July 3, 2026 as the record date for determining shareholder eligibility to receive dividend. The Board has recommended a final dividend of Rs. 1.00 per share (50% on face value of Rs. 2) and a special dividend of Rs. 2.00 per share (100%), totaling Rs. 3 per share for FY2026. This is subject to shareholder approval at the 22nd AGM scheduled for July 10, 2026, and payment will be made within 30 days of that approval. For context, standalone profit after tax declined to Rs. 1,116.40 million in FY2026 from Rs. 1,609.98 million in FY2025, with EPS falling from Rs. 10.76 to Rs. 7.29. This appears to be the company's first dividend since its IPO in August 2024.
Shareholders holding shares on July 3, 2026 will receive Rs. 3 per share, providing direct cash return. The dividend declaration is positive for investor sentiment, though the company saw significant profit decline year-on-year.